Agilent’s Acquisition Of Resolution Bioscience

Freshfields advised Agilent (NYSE: A) on its acquisition of Resolution Bioscience.The combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent’s…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now